Neurology

Study cognitive and functional change in everyday life

See how cognition, migraine, fatigue, mobility, sleep, and mood change between clinic visits, with continuous wearable signals and repeated patient- and caregiver-reported outcomes.

AT A GLANCE
16TB
of multimodal data in 12 weeks, with Lilly
113
adults, including 31 with MCI or mild Alzheimer’s
12 wk
prospective, observational feasibility study
KDD 2019
peer-reviewed publication of the results

Neurological change is gradual, variable, and hard to see in the clinic

Alzheimer's disease, MS, migraine, and Parkinson's progress or fluctuate over years, while clinic assessments capture only a few moments.

The gap

What today's data miss

  • How cognition, mobility, and function change between assessments
  • How migraine attacks, fatigue, or relapses affect daily life
  • Which everyday signals may precede measurable decline
  • How sleep, activity, and mood relate to disease activity

Open questions

What life sciences teams are asking

  • Can wearable and smartphone signals detect early change?
  • How do migraine frequency, triggers, and response vary?
  • What do fatigue, mobility, and relapses look like in MS?
  • Which digital measures could inform future endpoints?

Our approach

Measuring change in everyday life

  • Longitudinal tracking of cognition, symptoms, and function
  • High-frequency diaries for attacks, fatigue, and relapses
  • Passive activity, sleep, and step-pattern signals
  • Exploratory digital measures alongside clinical scales

Data for a better understanding of neurological conditions

Continuous engagement with patients and caregivers captures longitudinal data across cognition, symptoms, and behavior.

Who patients are
  • Age, sex, gender identity, race and ethnicity
  • Income, education, employment, household
  • Insurance, out-of-pocket costs, affordability
  • Access barriers: transportation, food, care
What they experience
  • Attacks, fatigue, pain, mood, cognitive complaints
  • MIDAS, HIT-6, MSIS-29, PHQ-9
  • Caregiver-reported changes in function
What they do
  • Activity, step patterns, sleep, heart rate
  • Work, social participation, daily function
  • Routine changes linked to disease activity
Treatment experience
  • Medication history, persistence, adherence
  • Switching and reported response
  • Acute vs. preventive use, side effects
Digital measures
  • Smartphone cognitive and motor tasks
  • Mobility, sleep regularity, daily routine
  • Feasibility data for future endpoints
Variation in burden
  • Progression, attack frequency, severity
  • Variability in treatment response
  • Quality of life and daily function
Clinical data
  • Diagnoses, imaging, or labs (EHR), where available
  • Neurology visits, procedures, treatments
  • Healthcare utilization across settings
Real-world outcomes
  • Cognitive, functional, symptom trajectories
  • Functional impact and quality of life
  • Long-term response and disease control
Trusted by leading life sciences companies:

Inside a neurology study

With Lilly, we looked for digital signals of cognitive decline in everyday devices.

16TB
of multimodal data collected in 12 weeks
113
adults: 31 with MCI or mild Alzheimer's, 82 healthy controls
KDD
peer-reviewed publication (2019)

Study design

Question

Can everyday consumer devices distinguish people with cognitive impairment from healthy controls?

Design

12-week prospective, observational feasibility study.

Data

Smartphone, smartwatch, tablet, and sleep-sensor signals, plus app tasks and surveys.

Outcome

Digital features that differed between groups.

Real-world insights in neurology

Research, webinars, and news from our work with people living with neurological conditions.

Let's design your next study

Tell us the question you need to answer. Our scientists will show you which cohorts, data types, and study designs can get you there, and how quickly.